Merit Medical (MMSI) Systems announced a significant milestone for breast cancer treatment: SCOUT Radar Localization use has reached 750,000 patients worldwide. Radar localization helps physicians surgically remove abnormal breast tissue while reducing trauma to surrounding healthy tissue. By implanting a tiny reflector, approximately the size of a grain of rice, physicians can use SCOUT to target affected tissue within +/- 1 mm of accuracy, which may result in more successful surgeries and improved patient care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical Systems: Promising Growth Potential Driven by Innovation, Strategic Acquisitions, and Strong Financials
- Merit Medical announces first patient enrolled WRAP North America registry
- Merit Medical Systems: Strong Performance, Strategic Growth, and Positive Outlook Justify Buy Rating
- Merit Medical launches Prelude Wave Hydrophilic Sheath Introducer
- Merit Medical Systems: Strong Performance and Strategic Growth Drive Buy Rating Despite Reimbursement Challenges